BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34516556)

  • 21. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism.
    Wen H; Cho HR; Yun T; Kim H; Park CK; Lee SH; Choi SH; Park S
    J Neurochem; 2015 Jan; 132(2):183-93. PubMed ID: 25251602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.
    Wieman HL; Wofford JA; Rathmell JC
    Mol Biol Cell; 2007 Apr; 18(4):1437-46. PubMed ID: 17301289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells.
    Jóźwiak P; Krześlak A; Bryś M; Lipińska A
    Oncol Rep; 2015 Feb; 33(2):913-20. PubMed ID: 25502934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactate dehydrogenase A silencing in IDH mutant gliomas.
    Chesnelong C; Chaumeil MM; Blough MD; Al-Najjar M; Stechishin OD; Chan JA; Pieper RO; Ronen SM; Weiss S; Luchman HA; Cairncross JG
    Neuro Oncol; 2014 May; 16(5):686-95. PubMed ID: 24366912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
    Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
    J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foxp3 and Toll-like receptor signaling balance T
    Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
    Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
    Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
    World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant IDH1 inhibits PI3K/Akt signaling in human glioma.
    Birner P; Pusch S; Christov C; Mihaylova S; Toumangelova-Uzeir K; Natchev S; Schoppmann SF; Tchorbanov A; Streubel B; Tuettenberg J; Guentchev M
    Cancer; 2014 Aug; 120(16):2440-7. PubMed ID: 24771584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
    Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF
    Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
    Reitman ZJ; Yan H
    J Natl Cancer Inst; 2010 Jul; 102(13):932-41. PubMed ID: 20513808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway.
    Carbonneau M; M Gagné L; Lalonde ME; Germain MA; Motorina A; Guiot MC; Secco B; Vincent EE; Tumber A; Hulea L; Bergeman J; Oppermann U; Jones RG; Laplante M; Topisirovic I; Petrecca K; Huot MÉ; Mallette FA
    Nat Commun; 2016 Sep; 7():12700. PubMed ID: 27624942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDH1 and IDH2 mutations in gliomas and the associated induction of hypoxia-inducible factor and production of 2-hydroxyglutarate.
    Komotar RJ; Starke RM; Sisti MB; Connolly ES
    Neurosurgery; 2010 Apr; 66(4):N20-1. PubMed ID: 20305482
    [No Abstract]   [Full Text] [Related]  

  • 34. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.
    Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N
    Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation.
    Fujiwara H; Tateishi K; Misumi K; Hayashi A; Igarashi K; Kato H; Nakatsuka T; Suzuki N; Yamamoto K; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Ijichi H; Kogure H; Nakai Y; Isayama H; Hasegawa K; Fukayama M; Soga T; Koike K
    Sci Rep; 2019 Dec; 9(1):18859. PubMed ID: 31827136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAPP Adaptors Control B Cell Metabolism by Modulating the Phosphatidylinositol 3-Kinase Signaling Pathway: A Novel Regulatory Circuit Preventing Autoimmunity.
    Jayachandran N; Mejia EM; Sheikholeslami K; Sher AA; Hou S; Hatch GM; Marshall AJ
    J Immunol; 2018 Jul; 201(2):406-416. PubMed ID: 29884706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis.
    Yang X; Cheng Y; Li P; Tao J; Deng X; Zhang X; Gu M; Lu Q; Yin C
    Tumour Biol; 2015 Jan; 36(1):383-91. PubMed ID: 25266796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.
    Lenting K; Khurshed M; Peeters TH; van den Heuvel CNAM; van Lith SAM; de Bitter T; Hendriks W; Span PN; Molenaar RJ; Botman D; Verrijp K; Heerschap A; Ter Laan M; Kusters B; van Ewijk A; Huynen MA; van Noorden CJF; Leenders WPJ
    FASEB J; 2019 Jan; 33(1):557-571. PubMed ID: 30001166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.